Favicon
Favicon

Charles Evavold Awarded Karin Grunebaum Cancer Research Foundation Faculty Research Fellowship

Date: June 25, 2024 By: Nick Kolev

Ragon faculty member and Early Independence Fellow Charles Evavold, PhD, has been selected as the recipient of the prestigious 2024-2025 Karin Grunebaum Cancer Research Foundation Faculty Research Fellowship at Harvard Medical School. The fellowship selection committee was deeply impressed by Evavold’s accomplishments and his potential for leadership in cancer research.

Evavold was also invited to present his research at the semiannual meeting of the board of the Karin Grunebaum Cancer Research Foundation, which will be held at Boston University Medical Center on Friday, June 14. 

Evavold is a Principal Investigator at the Ragon Institute and an Instructor at Harvard Medical School. His research focuses on synthetic immunity and cell death regulation, studying fundamental cellular decision-making using cell death programs as a model system. His lab aims to uncover novel regulation in these processes, combining genomic or chemical perturbations with synthetic biology models.

The Karin Grunebaum Cancer Research Foundation is dedicated to advancing cancer research and supporting scientists who show exceptional promise in this vital area of medical science.

Congratulations, Dr. Evavold!

More News

“A Wonderful Opportunity” – An Interview with Ragon Postdoc and Ramón Areces Foundation Research Fellow Gema González Rubio

González Rubio discusses the circumstances that brought her to the Ragon and how she hopes to grow from it

Press Releases

Ragon Study Reveals Critical Insights into RSV Immunity in Infants

Postdoctoral fellow Nadège Nziza was the first author of the study, published in Immunity, which explores how the immune responses of infants to RSV change over time.

Press Releases

HARVARD GAZETTE – How Ragon Institute’s new home aids mission

Immunology focus expands to neurodegenerative diseases and other areas as collaboration between Harvard, MIT, and Mass. General Hospital turns 15